Document is current
Any future updates will be listed below
-
Authors
Pouryousefi, Elahe
Javadi, Maryam
Hashemipour, Sima
Nooshabadi, Mohamadreza Rashidi
Haghighian, Hossein Khadem
-
Clinical Trials BETA
Clinical trials referenced in this document:
irct20141025019669n16 at Iranian Registry of Clinical TrialsDocuments that mention this clinical trial
Improved glycemic status, insulin resistance and inflammation after receiving oral oleoylethanolamide supplement in people with prediabetes: a randomized controlled trial
https://doi.org/10.1186/s13098-022-00848-3
-
Funding
Funding for this research was provided by:
Qazvin University of Medical Sciences (IR.QUMS.REC.1399.482, IR.QUMS.REC.1399.482, IR.QUMS.REC.1399.482, IR.QUMS.REC.1399.482, IR.QUMS.REC.1399.482)
- License Information
-
More Information
Article History
Received: 22 February 2022
Accepted: 16 May 2022
First Online: 3 June 2022
Declarations
:
: We confirm that any aspect of the work covered in this manuscript that has involved either human patient has been conducted with the ethical approval of all relevant bodies, in Ethical committee of Qazvin University of Medical Science, Qazvin, Iran by grant number of IR.QUMS.REC.1399.482. On the other hand, the protocol was registered in IRCT by number IRCT20141025019669N16. All the eligible and volunteered subjects had been written consent for supplementary care prior to research.
: Not applicable.
: The authors declare that they have no competing interests.
